Hennion & Walsh Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Hennion & Walsh Asset Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.15M	Buy
2025 Q2	$1.76M	Buy
2025 Q1	$1.28M	Buy
2024 Q4	$634K	Buy